Akèy › Kansè (tout kalite) › Wisconsin › Madison
Etid klinik pou Kansè (tout kalite) nan Madison, WI
14 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Madison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of ASP3082 in Adults With Advanced Solid Tumors
Ap rekriteFaz 1
- University of Wisconsin Hospital, Madison
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Ap rekriteFaz 3
- University of Wisconsin /ID# 279909, Madison
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Ap rekriteFaz 2/3
- University Of Wisconsin, Madison
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Ap rekriteFaz 2
- University of Wisconsin at Madison, Madison
Evaluating the Communication Between Patients and Providers in Cancer Clinics
Ap rekrite
- University of Wisconsin - Madison, Madison
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Ap rekriteFaz 1/2
- University of Wisconsin, Madison
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- SSM Health Dean Medical Group - South Madison Campus Health Research/Circuit Clinical, Madison
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- University of Wisconsin, Carbone Cancer Center, Madison
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- University of Wisconsin- Madison, Madison
Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery
Ap rekriteEtid obsèvasyon
- UW Health, Madison
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Ap rekriteFaz 1
- University of Wisconsin, Madison
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Ap rekrite
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Ap rekrite
- University of Winsconsin Carbone Cancer Center-Eastpark medical Center, Madison
- University of Wisconsin Carbone Cancer Center, Madison
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY110 etid
- Boston, MA86 etid
- Los Angeles, CA73 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Durham, NC58 etid
- Washington, DC58 etid
- Chicago, IL51 etid
- Seattle, WA49 etid
- Atlanta, GA49 etid
- Arlington, VA48 etid
Lòt etid nan Madison
- Kansè pwostat29 etid
- Kansè kolorektal22 etid
- Kansè nan tete22 etid
- Kansè Metastatik21 etid
- Kansè Poumon ki pa ti selil16 etid
- Leksemi mieloïd egi16 etid
- Melanom15 etid
- Kansè ovè13 etid
- Kansè lestomak11 etid
- Kansè poumon10 etid
- Kansè pankreyas10 etid
- Myelom Miltip9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.